Biofil Chemicals & Pharmaceuticals
Biofil Chemicals & Pharmaceuticals Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Biofil Chemicals & Pharmaceuticals
Start SIPBiofil Chemicals & Pharmaceuticals F&O
Biofil Chemicals & Pharmaceuticals Investment Rating
-
Master Rating:
-
Biofil Chemicals & Pharmaceuticals has an operating revenue of Rs. 18.07 Cr. on a trailing 12-month basis. An annual revenue de-growth of -38% needs improvement, Pre-tax margin of 5% is okay, ROE of 4% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 19 which is a POOR score indicating inconsistency in earnings, a RS Rating of 27 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 81 indicates it belongs to a poor industry group of Medical-Ethical Drugs and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 1 | 3 | 12 | 2 |
| Operating Expenses Qtr Cr | 1 | 2 | 12 | 2 |
| Operating Profit Qtr Cr | 0 | 0 | 0 | 0 |
| Depreciation Qtr Cr | 0 | 0 | 0 | 0 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 0 | 0 | 0 | 0 |
| Net Profit Qtr Cr | 0 | 0 | 0 | 0 |
Biofil Chemicals & Pharmaceuticals Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- 43.13
- 50 Day
- 46.01
- 100 Day
- 48.68
- 200 Day
- 52.01
- 20 Day
- 43.06
- 50 Day
- 46.65
- 100 Day
- 50.6
- 200 Day
- 51.1
Biofil Chemicals & Pharmaceuticals Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 42.9 |
| Second Resistance | 44 |
| Third Resistance | 44.7 |
| RSI | 40.83 |
| MFI | 51.32 |
| MACD Single Line | -1.56 |
| MACD | -1.42 |
| Support | |
|---|---|
| First Resistance | 41.1 |
| Second Resistance | 40.4 |
| Third Resistance | 39.3 |
Biofil Chemicals & Pharmaceuticals Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 32,336 | 2,013,886 | 62.28 |
| Week | 34,675 | 1,974,034 | 56.93 |
| 1 Month | 28,005 | 1,681,432 | 60.04 |
| 6 Month | 82,165 | 3,420,532 | 41.63 |
Biofil Chemicals & Pharmaceuticals Result Highlights
Biofil Chemicals & Pharmaceuticals Synopsis
NSE-Medical-Ethical Drugs
Biofil Chemicals belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 22.38 Cr. and Equity Capital is Rs. 16.27 Cr. for the Year ended 31/03/2022. Biofil Chemicals & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 04/01/1985 and has its registered office in the State of Madhya Pradesh, India. Company’s Corporate Identification Number(CIN) is L24233MP1985PLC002709 and registration number is 002709.| Market Cap | 67 |
| Sales | 18 |
| Shares in Float | 0.86 |
| No of funds | 6 |
| Yield |
| Book Value | 3.99 |
| U/D Vol ratio | 0.5 |
| LTDebt / Equity | |
| Alpha | -0.03 |
| Beta | 0.76 |
Biofil Chemicals & Pharmaceuticals
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 46.82% | 46.82% | 46.82% | |
| Foreign Portfolio Investors | ||||
| Financial Institutions/ Banks | 0.04% | 0.04% | 0.08% | |
| Individual Investors | 38.04% | 37.87% | 37.84% | |
| Others | 15.1% | 15.27% | 15.26% |
Biofil Chemicals & Pharmaceuticals Management
| Name | Designation |
|---|---|
| Mr. Ramesh Shah | Managing Director |
| Mr. Ketan Shah | Whole Time Director |
| Mr. Romil Shah | Non Executive Director |
| Mrs. Shaila Jain | Independent Director |
| Mr. Satish Beohar | Independent Director |
| Mr. Ashok Kumar Ramawat | Independent Director |
Biofil Chemicals & Pharmaceuticals Forecast
Price Estimates
Biofil Chemicals & Pharmaceuticals FAQs
What is Share Price of Biofil Chemicals & Pharmaceuticals ?
Biofil Chemicals & Pharmaceuticals share price is ₹41 As on 31 March, 2023 | 21:48
What is the Market Cap of Biofil Chemicals & Pharmaceuticals ?
The Market Cap of Biofil Chemicals & Pharmaceuticals is ₹67.4 Cr As on 31 March, 2023 | 21:48
What is the P/E ratio of Biofil Chemicals & Pharmaceuticals ?
The P/E ratio of Biofil Chemicals & Pharmaceuticals is 208.4 As on 31 March, 2023 | 21:48
What is the PB ratio of Biofil Chemicals & Pharmaceuticals ?
The PB ratio of Biofil Chemicals & Pharmaceuticals is 4 As on 31 March, 2023 | 21:48